Difficulty Passing motion? Don't worry, there is a hope to retrain your bowel!

Constipation is a multifactorial condition often resistant to traditional laxatives. These modern agents target specific physiological pathways to enhance motility and secretion without causing dependency or electrolyte imbalance.

Mechanistic Insights

• Resolor (Prucalopride) acts on serotonin receptors in the gut wall, directly stimulating propulsive motility. It’s particularly effective for patients who fail to respond to osmotic or stimulant laxatives.

• Goofice (Elobixibat) inhibits the ileal bile acid transporter, increasing bile acid concentration in the colon. This enhances secretion and motility, offering a novel, non‑laxative approach to chronic constipation.

• Constella (Linaclotide) activates guanylate cyclase‑C receptors on intestinal epithelial cells, increasing cyclic GMP and chloride secretion, which softens stool and reduces visceral pain.

Conclusion

The combination of Resolor, Goofice, and Constella represents a major advancement in gastroenterology. By targeting distinct physiological pathways, these agents provide personalized, mechanism‑based relief for patients with chronic constipation and IBS‑C. Their complementary actions—motility stimulation, bile acid regulation, and fluid secretion—offer clinicians a versatile toolkit for optimizing bowel health and improving quality of life.